Aurobindo Pharma plans expansion programme in Pydibhimavaram
Aurobindo Pharma is planning to expand its bulk drug unit in Pydibhimavaram/Chittivalasa in Ranasthalam Mandal in Srikakulam district of Andhra Pradesh. The project involves expanding […]
Aurobindo
Aurobindo Pharma receives USFDA approval to market potassium chloride
Aurobindo Pharma Ltd has received USFDA approval to market potassium chloride tablets of 600 mg and 750 mg in the US market. The tablet, a […]
Aurobindo Pharma receives USFDA approval for Vecuronium Bromide injection
Aurobindo Pharma has received final USFDA approval to manufacture and market Vecuronium Bromide Injection, 10mg and 20mg for the US markets. The drug Vecuronium Bromide […]
Aurobindo Pharma receives USFDA approval for Bivalirudin
Aurobindo Pharma has received final USFDA approval to manufacture and market Bivalirudin injection, 250 mg/vial. The drug Bivalirudin is a generic equivalent to the reference […]
Aurobindo Pharma receives USFDA approval for linezolid injection
Aurobindo Pharma has received final USFDA approval to manufacture and market Linezolid injection which is an anti-infective and is used to treat infections caused by […]
Aurobindo Pharma receives final USFDA approval for Rosuvastatin
Aurobindo Pharma has received final USFDA approval for Rosuvastatin calcium tablets which are prescribed for lowering cholesterol. Rosuvastatin calcium tablets are the generic version of […]
Aurobindo Pharma receives USFDA approval for Fenofibrate
Aurobindo Pharma has received final approval from the USFDA to manufacture and market Fenofibrate tablets which are used for the treatment of high level of […]
Aurobindo Pharma receives USFDA approval for Rivastigmine Tartrate
Aurobindo Pharma has received final USFDA to manufacture and market Rivastigmine Tartrate Capsules USP which is used for the treatment of dementia disease, in the […]
Aurobindo Pharma receives USFDA approval for pantoprazole
Aurobindo Pharma has received final USFDA approval to manufacture and market pantoprazole sodium for injections, used for the treatment of gastroesophageal reflux disease, in the […]
Aurobindo Pharma receives USFDA approval for valganciclovir
Aurobindo Pharma has received final USFDA approval to manufacture and market valganciclovir tablets USP, 450 mg. This product is to be launched in Q1 FY16-17. […]